Skip to content

13F-HR filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 51 holding rows worth $641,735,000.

Accession
0001511901-18-000003
Filed
2018-05-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 51 entries on the cover page, a total value of $641,735,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $641,735,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerBroadfin Healthcare Master Fund Ltd 028-14254

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 21,656,720$49,337,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM1,443,948$44,329,000thousands by filing date
HERON THERAPEUTICS INC427746102COM1,581,416$43,647,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS2,564,175$36,411,000thousands by filing date
CORIUM INTL INC21887L107COM3,119,645$35,782,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM1,135,203$27,131,000thousands by filing date
RETROPHIN INC761299106COM1,178,226$26,345,000thousands by filing date
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,793,752$24,725,000thousands by filing date
SOCIETAL CDMO INC75629F109COM2,236,025$24,619,000thousands by filing date
ZOGENIX INC.98978L204Common Stock537,380$21,522,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS175,030$19,721,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO2,624,663$19,134,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM4,294,426$18,938,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW298,424$16,515,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM6,812,764$16,283,000thousands by filing date
ANGIODYNAMICS INC03475V101COM911,707$15,727,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM912,987$15,429,000thousands by filing date
NUVASIVE INC670704105COM258,292$13,485,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM598,800$12,066,000thousands by filing date
KALA BIO INC COM483119103Stock681,239$10,784,000thousands by filing date
ANTARES PHARMA INC036642106COM4,673,247$10,281,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM4,278,819$9,627,000thousands by filing date
GLAUKOS CORP COM377322102Stock293,900$9,061,000thousands by filing date
ANAPTYSBIO INC032724106COM79,200$8,243,000thousands by filing date
CIGNA CORPORATION125509109COM42,600$7,146,000thousands by filing date
Merck & Co.,Inc.58933Y105COM130,900$7,130,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW1,948,554$6,820,000thousands by filing date
SOL GEL TECHNOLOGIESM8694L103SHS647,700$6,671,000thousands by filing date
VERICEL CORP92346J108COM658,900$6,556,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock86,786$6,277,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW2,078,799$6,257,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity477,607$6,209,000thousands by filing date
PERNIX THERAPEUTICS HLDGS IN71426VAK4DBCV 4.250 4/015,000,000$6,027,000thousands by filing date
TELIGENT INC NEW87960W104COM1,690,794$5,681,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock166,500$5,186,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS374,233$4,659,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS300,000$4,260,000thousands by filing datecall
NATUS MEDICAL INC639050103COM113,526$3,820,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM500,000$3,730,000thousands by filing datecall
VARIAN MED SYS INC92220P105COM30,000$3,680,000thousands by filing date
INVITAE CORP46185L103COM750,000$3,518,000thousands by filing date
VERACYTE INC COM92337F107Stock600,658$3,340,000thousands by filing date
ADMA BIOLOGICS INC000899104COM720,529$3,314,000thousands by filing date
TETRAPHASE PHARMACEUTICALS INC88165N105COMMON STOCK1,048,642$3,219,000thousands by filing date
MEDIWOUND LTDM68830104ORD SHS500,000$2,600,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,885,904$2,527,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock375,816$1,503,000thousands by filing date
INVUITY INC46187J205COM NEW298,800$1,150,000thousands by filing date
CONTRAFECT CORP212326102COM389,475$633,000thousands by filing date
OVASCIENCE INC69014Q101COM545,282$442,000thousands by filing date
STRATA SKIN SCIENCES INC86272A206COMMON203,346$238,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001511901-18-000003this filing2018-05-14acceptance time not in the bulk data set